Table 1.
Results of patient telephone survey
| Patient details | |
|---|---|
| Patients contacted | n = 106 |
| Consented to survey | n = 96 |
| Tumour type (N = x) | |
|
Renal Bladder Prostate Melanoma Lung Testicular Breast Lymphoma |
20 13 8 16 12 8 16 3 |
| Time since diagnosis (months) | |
|
< 3 months 3–6 months 6–12 months > 12 months |
7 8 12 72 |
| Gender (N = x) | |
|
Male Female |
54 42 |
| Age (years) | |
| Median, [range] | 64, [28–90] |
| Disease status from most recent results/imaging | |
|
No recurrence Complete response Partial response Stable disease Progressive disease |
18 17 8 27 23 |
| Treatment modality (N = x) | |
|
SACT Post-surgical surveillance Watchful waiting |
68 18 10 |
| Number of lines of SACT | |
| Median, [range] | 1, [0–6] |
| Duration of current treatment (months) | |
| Median, [range] | 4, [0–51] |
| ECOG | |
| Median, [range] | 1, [0–3] |
| Current frequency of visits (weeks) | |
| Median, [range] | 4, [2–28] |
| Fluent English | |
| Number, [%] | 94, [97.9%] |
| Telemedicine | |
|
How much do you agree with the following (0–10): Median, [range] | |
| I was satisfied with the format | 10, [5–10] |
| There was adequate time given to the consultation | 10, [4–10] |
| I felt able to ask questions | 10, [2–10] |
| Information was delivered in a sensitive/supportive manner | 10, [2–10] |
| Compound score (/40) | 40, [15–40] |
| Would you be happy to have teleclinics outside of the current pandemic? | |
| Number responding “Yes”, [%] | 87, [90.6%] |
|
Which would you be happy to have over the phone?: Number responding “Yes”, [%] | |
| Blood results (Favourable) | 96, [100.0%] |
| Blood results (Unfavourable) | 83, [86.5%] |
| Scan results (Favourable) | 87, [90.6%] |
| Scan results (Unfavourable) | 55, [57.3%] |
| Symptom review (e.g. pain, medications, treatment toxicity) | 71, [74.0%] |
| Discussion of new treatment/consent | 48, [50.0%] |
| How much notice would you like if a clinic was to be changed to tele from face-to-face or vice versa? (N = x) | |
|
0–24 h 24–48 h 2–7 days 1–2 weeks > 2 weeks |
12 47 32 5 0 |
|
Did your cancer treatment change as a result of COVID (Yes/No) Number, [%] |
32, [33.3%] |
| If so, how? (N = x)AQ | |
|
Delay to treatment (including surgery) Change of treatment frequency Change of treatment type Stop treatment |
11 17 3 1 |